EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
08 janv. 2024 08h00 HE
|
EDAP TMS S.A.
Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital sales LYON, France, January 8, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in...
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
02 janv. 2024 08h00 HE
|
EDAP TMS S.A.
LYON, France, January 2, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that the Company has appointed Ken Mobeck as its Chief...
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
12 déc. 2023 08h00 HE
|
EDAP TMS S.A.
Represents Key Milestone Toward Universal Coverage for Focal One HIFU in France LYON, France, December 12, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based...
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
06 déc. 2023 16h30 HE
|
EDAP TMS S.A.
LYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Lance Willsey, M.S.,...
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
30 nov. 2023 08h00 HE
|
EDAP TMS S.A.
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the...
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
20 nov. 2023 08h00 HE
|
EDAP TMS S.A.
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...
EDAP Announces Third Quarter 2023 Financial Results
09 nov. 2023 06h00 HE
|
EDAP TMS S.A.
- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year - - Record nine months HIFU revenues reflecting growing demand - - Two additional Focal One systems...
EDAP to Present at the Jefferies London Healthcare Conference
06 nov. 2023 08h00 HE
|
EDAP TMS S.A.
LYON, France, November 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...
EDAP TMS SA to Announce Third Quarter 2023 Financial Results on November 9, 2023
26 oct. 2023 08h00 HE
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 9th at 8:30am EDT LYON, France, October 26, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...
EDAP to Present at Morgan Stanley Annual Global Healthcare Conference and the H.C. Wainwright Annual Global Investment Conference
06 sept. 2023 08h00 HE
|
EDAP TMS S.A.
LYON, France, September 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...